Rank | Gene Set | Z-score |
---|---|---|
1 | negative T cell selection (GO:0043383) | 8.60076741 |
2 | negative thymic T cell selection (GO:0045060) | 7.93074660 |
3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 7.75146120 |
4 | positive T cell selection (GO:0043368) | 7.33274941 |
5 | positive thymic T cell selection (GO:0045059) | 7.06712154 |
6 | regulation of gamma-delta T cell differentiation (GO:0045586) | 6.88178264 |
7 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.76108703 |
8 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.76108703 |
9 | thymic T cell selection (GO:0045061) | 6.75461730 |
10 | regulation of isotype switching to IgG isotypes (GO:0048302) | 6.63382383 |
11 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 6.59787272 |
12 | negative regulation of cell killing (GO:0031342) | 6.53992790 |
13 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.53992790 |
14 | T cell selection (GO:0045058) | 6.51884658 |
15 | interferon-gamma production (GO:0032609) | 6.29201213 |
16 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 6.22236747 |
17 | regulation of gamma-delta T cell activation (GO:0046643) | 6.20858201 |
18 | response to interleukin-15 (GO:0070672) | 5.60574475 |
19 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.53614142 |
20 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 5.51930688 |
21 | activated T cell proliferation (GO:0050798) | 5.49157254 |
22 | T cell receptor signaling pathway (GO:0050852) | 5.48384926 |
23 | regulation of T cell tolerance induction (GO:0002664) | 5.44424801 |
24 | cytidine deamination (GO:0009972) | 5.37976763 |
25 | cytidine metabolic process (GO:0046087) | 5.37976763 |
26 | cytidine catabolic process (GO:0006216) | 5.37976763 |
27 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 5.33329017 |
28 | T cell migration (GO:0072678) | 5.20005558 |
29 | cellular response to interleukin-15 (GO:0071350) | 5.16998940 |
30 | T cell costimulation (GO:0031295) | 4.95115234 |
31 | leukocyte aggregation (GO:0070486) | 4.92164795 |
32 | lymphocyte costimulation (GO:0031294) | 4.85558424 |
33 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 4.78134054 |
34 | regulation of alpha-beta T cell proliferation (GO:0046640) | 4.74911269 |
35 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 4.68997967 |
36 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 4.68511816 |
37 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 4.68511816 |
38 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 4.64305375 |
39 | positive regulation of uterine smooth muscle contraction (GO:0070474) | 4.62797139 |
40 | positive regulation of isotype switching (GO:0045830) | 4.62149864 |
41 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 4.51854200 |
42 | regulation of natural killer cell mediated immunity (GO:0002715) | 4.49613316 |
43 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 4.49613316 |
44 | antigen receptor-mediated signaling pathway (GO:0050851) | 4.44981752 |
45 | positive regulation of interleukin-2 production (GO:0032743) | 4.41402143 |
46 | positive regulation of tolerance induction (GO:0002645) | 4.39528753 |
47 | lymphocyte chemotaxis (GO:0048247) | 4.39273884 |
48 | regulation of T cell receptor signaling pathway (GO:0050856) | 4.19925771 |
49 | negative regulation of T cell mediated immunity (GO:0002710) | 4.18802728 |
50 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 4.18555331 |
51 | positive regulation of B cell mediated immunity (GO:0002714) | 4.18555331 |
52 | positive regulation of immune response to tumor cell (GO:0002839) | 4.17609874 |
53 | regulation of immune response to tumor cell (GO:0002837) | 4.17609874 |
54 | regulation of response to tumor cell (GO:0002834) | 4.17609874 |
55 | positive regulation of response to tumor cell (GO:0002836) | 4.17609874 |
56 | DNA deamination (GO:0045006) | 4.15938426 |
57 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 4.10809897 |
58 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.05832942 |
59 | dendritic cell chemotaxis (GO:0002407) | 4.02150886 |
60 | positive regulation of humoral immune response (GO:0002922) | 4.01374572 |
61 | chemokine-mediated signaling pathway (GO:0070098) | 3.99245310 |
62 | positive regulation of DNA recombination (GO:0045911) | 3.93131614 |
63 | regulation of chronic inflammatory response (GO:0002676) | 3.90852574 |
64 | regulation of isotype switching (GO:0045191) | 3.89443584 |
65 | alpha-beta T cell differentiation (GO:0046632) | 3.87531693 |
66 | regulation of tolerance induction (GO:0002643) | 3.87425935 |
67 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.86175514 |
68 | mast cell activation (GO:0045576) | 3.85108508 |
69 | alpha-beta T cell activation (GO:0046631) | 3.84135415 |
70 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.81863191 |
71 | regulation of regulatory T cell differentiation (GO:0045589) | 3.79725375 |
72 | B cell receptor signaling pathway (GO:0050853) | 3.78346238 |
73 | T cell differentiation (GO:0030217) | 3.78051771 |
74 | positive regulation of cell killing (GO:0031343) | 3.71092947 |
75 | regulation of immunoglobulin mediated immune response (GO:0002889) | 3.68133500 |
76 | regulation of activation of Janus kinase activity (GO:0010533) | 3.67491120 |
77 | positive regulation of calcium-mediated signaling (GO:0050850) | 3.62428184 |
78 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.62239621 |
79 | regulation of B cell mediated immunity (GO:0002712) | 3.54907923 |
80 | negative regulation of execution phase of apoptosis (GO:1900118) | 3.54801368 |
81 | positive regulation of defense response to virus by host (GO:0002230) | 3.53717854 |
82 | regulation of response to interferon-gamma (GO:0060330) | 3.51207364 |
83 | V(D)J recombination (GO:0033151) | 3.49729483 |
84 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.47603192 |
85 | regulation of cell killing (GO:0031341) | 3.46927912 |
86 | negative regulation of T cell apoptotic process (GO:0070233) | 3.45217844 |
87 | tolerance induction (GO:0002507) | 3.44493909 |
88 | regulation of uterine smooth muscle contraction (GO:0070472) | 3.43886443 |
89 | negative regulation of B cell proliferation (GO:0030889) | 3.42960557 |
90 | T cell activation (GO:0042110) | 3.40281613 |
91 | positive regulation of immunoglobulin production (GO:0002639) | 3.38735170 |
92 | regulation of interleukin-2 production (GO:0032663) | 3.37245429 |
93 | positive regulation of T cell chemotaxis (GO:0010820) | 3.35943634 |
94 | regulation of T cell chemotaxis (GO:0010819) | 3.35943634 |
95 | gonadal mesoderm development (GO:0007506) | 3.35374993 |
96 | negative regulation of B cell activation (GO:0050869) | 3.35253539 |
97 | dendritic cell migration (GO:0036336) | 3.33105316 |
98 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.32995960 |
99 | T cell homeostasis (GO:0043029) | 3.30018346 |
100 | positive regulation of granulocyte differentiation (GO:0030854) | 3.29582085 |
101 | positive regulation of T cell differentiation in thymus (GO:0033089) | 3.29317850 |
102 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 3.29297585 |
103 | lymph node development (GO:0048535) | 3.27714843 |
104 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.24412282 |
105 | regulation of immunoglobulin production (GO:0002637) | 3.23253109 |
106 | regulation of defense response to virus by virus (GO:0050690) | 3.22986828 |
107 | positive regulation of lymphocyte mediated immunity (GO:0002708) | 3.19878597 |
108 | T cell proliferation (GO:0042098) | 3.19701962 |
109 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.18514957 |
110 | cellular response to interleukin-4 (GO:0071353) | 3.17262867 |
111 | lymphocyte migration (GO:0072676) | 3.15499500 |
112 | leukocyte cell-cell adhesion (GO:0007159) | 3.13675385 |
113 | regulation of interleukin-4 production (GO:0032673) | 3.13160395 |
114 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.13113373 |
115 | regulation of B cell differentiation (GO:0045577) | 3.12857696 |
116 | positive regulation of T cell activation (GO:0050870) | 3.12131319 |
117 | cellular defense response (GO:0006968) | 3.10171273 |
118 | positive regulation of interleukin-4 production (GO:0032753) | 3.09680352 |
119 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.08542417 |
120 | positive regulation of alpha-beta T cell activation (GO:0046635) | 3.08140698 |
121 | NIK/NF-kappaB signaling (GO:0038061) | 3.07171084 |
122 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.07107306 |
123 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 3.06450931 |
124 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.05516435 |
125 | viral transcription (GO:0019083) | 3.04210314 |
126 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.03957316 |
127 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.01927886 |
128 | signal complex assembly (GO:0007172) | 3.01083270 |
129 | regulation of lymphocyte mediated immunity (GO:0002706) | 3.00582457 |
130 | positive regulation of interleukin-8 secretion (GO:2000484) | 2.99637467 |
131 | Peyers patch development (GO:0048541) | 2.98652868 |
132 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.98652868 |
133 | regulation of alpha-beta T cell activation (GO:0046634) | 2.98253996 |
Rank | Gene Set | Z-score |
---|---|---|
1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 8.31625132 |
2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 6.51335121 |
3 | MYC_22102868_ChIP-Seq_BL_Human | 3.97452216 |
4 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.84567185 |
5 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.83484049 |
6 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.70793722 |
7 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.67631878 |
8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.50607729 |
9 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.45672927 |
10 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.37465849 |
11 | MYB_26560356_Chip-Seq_TH2_Human | 3.32133197 |
12 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.29073996 |
13 | MAF_26560356_Chip-Seq_TH1_Human | 2.97583423 |
14 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.89672131 |
15 | UTX_26944678_Chip-Seq_JUKART_Human | 2.80861165 |
16 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.77476425 |
17 | MYB_26560356_Chip-Seq_TH1_Human | 2.72340145 |
18 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.54836682 |
19 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.44122554 |
20 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.42662098 |
21 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.39575385 |
22 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.30279457 |
23 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.22901649 |
24 | MAF_26560356_Chip-Seq_TH2_Human | 2.21901933 |
25 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.19732556 |
26 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.17246900 |
27 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.12149499 |
28 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.07954375 |
29 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.00108638 |
30 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.89556020 |
31 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.86264488 |
32 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.77866367 |
33 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.77406515 |
34 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.77172153 |
35 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.72288183 |
36 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.71283679 |
37 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.70686714 |
38 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.70622788 |
39 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.68621596 |
40 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.66079947 |
41 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.64668971 |
42 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.61194317 |
43 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58926853 |
44 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.56955985 |
45 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.54453517 |
46 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49940868 |
47 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49094920 |
48 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.46913049 |
49 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.46843602 |
50 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.45472568 |
51 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.44011105 |
52 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.43777887 |
53 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.40649211 |
54 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.39568576 |
55 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.34487309 |
56 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31491810 |
57 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.28610996 |
58 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.28237677 |
59 | SPI1_23127762_ChIP-Seq_K562_Human | 1.27531767 |
60 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23751315 |
61 | GATA3_26560356_Chip-Seq_TH2_Human | 1.22630995 |
62 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.22186820 |
63 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.19836459 |
64 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.19568180 |
65 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.11954895 |
66 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.07154826 |
67 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.05891327 |
68 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.04901104 |
69 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.02239327 |
70 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.00719011 |
71 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.99240374 |
72 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.97995069 |
73 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.95828184 |
74 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.94520551 |
75 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.94108818 |
76 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.93841818 |
77 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.93473120 |
78 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.92193886 |
79 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.92101985 |
80 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.91354969 |
81 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.90948827 |
82 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.89733337 |
83 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.89561333 |
84 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.88623249 |
85 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88205717 |
86 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.88131542 |
87 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.87769795 |
88 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.85829536 |
89 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.85762232 |
90 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.85743475 |
91 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.85536917 |
92 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.85490005 |
93 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85206842 |
94 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.84935211 |
95 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.82986207 |
96 | GATA3_26560356_Chip-Seq_TH1_Human | 0.82402837 |
97 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.82144414 |
98 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.81705944 |
99 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.81329831 |
100 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.80955390 |
101 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.80591715 |
102 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.79144897 |
103 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.78596459 |
104 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.77974368 |
105 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.77703890 |
106 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.74489531 |
107 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.73678425 |
108 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.73304463 |
109 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.71469816 |
110 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.70202330 |
111 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.69807369 |
112 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.69091022 |
113 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.68391680 |
114 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.67518993 |
115 | GATA1_22025678_ChIP-Seq_K562_Human | 0.67485052 |
116 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.67213987 |
117 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.66927557 |
118 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.66719796 |
119 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.65861278 |
120 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.65737766 |
121 | GATA1_19941826_ChIP-Seq_K562_Human | 0.65252223 |
122 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.64897058 |
123 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.64333818 |
124 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.63966820 |
125 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.63797425 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003763_abnormal_thymus_physiology | 6.28375895 |
2 | MP0005671_abnormal_response_to | 4.53612714 |
3 | MP0000685_abnormal_immune_system | 3.88505595 |
4 | MP0009333_abnormal_splenocyte_physiolog | 3.28941089 |
5 | MP0001835_abnormal_antigen_presentation | 3.11342217 |
6 | MP0000703_abnormal_thymus_morphology | 3.09785994 |
7 | MP0001800_abnormal_humoral_immune | 3.08801096 |
8 | MP0002398_abnormal_bone_marrow | 3.01274785 |
9 | MP0002166_altered_tumor_susceptibility | 3.00565597 |
10 | MP0002405_respiratory_system_inflammati | 2.88257513 |
11 | MP0002420_abnormal_adaptive_immunity | 2.85067495 |
12 | MP0005000_abnormal_immune_tolerance | 2.80367021 |
13 | MP0001819_abnormal_immune_cell | 2.79283614 |
14 | MP0005451_abnormal_body_composition | 2.78899616 |
15 | MP0002723_abnormal_immune_serum | 2.77925632 |
16 | MP0005387_immune_system_phenotype | 2.72590356 |
17 | MP0001790_abnormal_immune_system | 2.72590356 |
18 | MP0002396_abnormal_hematopoietic_system | 2.64796321 |
19 | MP0003436_decreased_susceptibility_to | 2.56968508 |
20 | MP0009785_altered_susceptibility_to | 2.56862140 |
21 | MP0001873_stomach_inflammation | 2.55758912 |
22 | MP0002006_tumorigenesis | 2.54994245 |
23 | MP0000716_abnormal_immune_system | 2.54545986 |
24 | MP0002722_abnormal_immune_system | 2.48130085 |
25 | MP0003866_abnormal_defecation | 2.47201134 |
26 | MP0003300_gastrointestinal_ulcer | 2.46076501 |
27 | MP0002452_abnormal_antigen_presenting | 2.46068764 |
28 | MP0000689_abnormal_spleen_morphology | 2.34601160 |
29 | MP0005025_abnormal_response_to | 2.32571428 |
30 | MP0006082_CNS_inflammation | 2.25926662 |
31 | MP0010155_abnormal_intestine_physiology | 2.22468952 |
32 | MP0002277_abnormal_respiratory_mucosa | 2.14351104 |
33 | MP0002429_abnormal_blood_cell | 2.09158631 |
34 | MP0004947_skin_inflammation | 2.04687596 |
35 | MP0003724_increased_susceptibility_to | 1.91557871 |
36 | MP0004381_abnormal_hair_follicle | 1.85835558 |
37 | MP0003303_peritoneal_inflammation | 1.85665820 |
38 | MP0004808_abnormal_hematopoietic_stem | 1.81573493 |
39 | MP0002933_joint_inflammation | 1.80436010 |
40 | MP0002148_abnormal_hypersensitivity_rea | 1.76000408 |
41 | MP0002163_abnormal_gland_morphology | 1.71081611 |
42 | MP0004510_myositis | 1.66674374 |
43 | MP0001845_abnormal_inflammatory_respons | 1.66495320 |
44 | MP0002419_abnormal_innate_immunity | 1.63300108 |
45 | MP0005464_abnormal_platelet_physiology | 1.61733924 |
46 | MP0003806_abnormal_nucleotide_metabolis | 1.50047265 |
47 | MP0001853_heart_inflammation | 1.44936849 |
48 | MP0000858_altered_metastatic_potential | 1.42821102 |
49 | MP0003448_altered_tumor_morphology | 1.28253772 |
50 | MP0002132_abnormal_respiratory_system | 1.22607562 |
51 | MP0005075_abnormal_melanosome_morpholog | 1.17875164 |
52 | MP0002019_abnormal_tumor_incidence | 1.15711680 |
53 | MP0009764_decreased_sensitivity_to | 1.11973360 |
54 | MP0008961_abnormal_basal_metabolism | 1.11592607 |
55 | MP0003786_premature_aging | 1.10494881 |
56 | MP0005310_abnormal_salivary_gland | 1.09279832 |
57 | MP0000465_gastrointestinal_hemorrhage | 1.06363562 |
58 | MP0008469_abnormal_protein_level | 1.01315027 |
59 | MP0010352_gastrointestinal_tract_polyps | 0.98348383 |
60 | MP0008057_abnormal_DNA_replication | 0.98289586 |
61 | MP0005397_hematopoietic_system_phenotyp | 0.97450210 |
62 | MP0001545_abnormal_hematopoietic_system | 0.97450210 |
63 | MP0000490_abnormal_crypts_of | 0.95412918 |
64 | MP0001533_abnormal_skeleton_physiology | 0.95359558 |
65 | MP0001851_eye_inflammation | 0.93443145 |
66 | MP0009765_abnormal_xenobiotic_induced | 0.86804131 |
67 | MP0004957_abnormal_blastocyst_morpholog | 0.85585775 |
68 | MP0002876_abnormal_thyroid_physiology | 0.84333198 |
69 | MP0002998_abnormal_bone_remodeling | 0.84302098 |
70 | MP0005023_abnormal_wound_healing | 0.80117316 |
71 | MP0001542_abnormal_bone_strength | 0.79449827 |
72 | MP0005379_endocrine/exocrine_gland_phen | 0.79243011 |
73 | MP0003329_amyloid_beta_deposits | 0.77556868 |
74 | MP0001919_abnormal_reproductive_system | 0.77260950 |
75 | MP0003077_abnormal_cell_cycle | 0.77147422 |
76 | MP0000372_irregular_coat_pigmentation | 0.76308381 |
77 | MP0002009_preneoplasia | 0.74757489 |
78 | MP0002254_reproductive_system_inflammat | 0.72004407 |
79 | MP0001346_abnormal_lacrimal_gland | 0.70905277 |
80 | MP0002138_abnormal_hepatobiliary_system | 0.69775875 |
81 | MP0005076_abnormal_cell_differentiation | 0.67114825 |
82 | MP0001243_abnormal_dermal_layer | 0.66847071 |
83 | MP0003252_abnormal_bile_duct | 0.66145086 |
84 | MP0002168_other_aberrant_phenotype | 0.65151080 |
85 | MP0010307_abnormal_tumor_latency | 0.64791161 |
86 | MP0004883_abnormal_blood_vessel | 0.62771282 |
87 | MP0000920_abnormal_myelination | 0.62735583 |
88 | MP0000609_abnormal_liver_physiology | 0.62669406 |
89 | MP0009278_abnormal_bone_marrow | 0.62405244 |
90 | MP0005390_skeleton_phenotype | 0.62369622 |
91 | MP0009763_increased_sensitivity_to | 0.61946976 |
92 | MP0003693_abnormal_embryo_hatching | 0.61008024 |
93 | MP0003646_muscle_fatigue | 0.60856913 |
94 | MP0003795_abnormal_bone_structure | 0.60288641 |
95 | MP0010094_abnormal_chromosome_stability | 0.59570479 |
96 | MP0000343_altered_response_to | 0.59135455 |
97 | MP0003045_fibrosis | 0.58859604 |
98 | MP0000249_abnormal_blood_vessel | 0.55749974 |
99 | MP0000477_abnormal_intestine_morphology | 0.54458225 |
100 | MP0001663_abnormal_digestive_system | 0.54183765 |
101 | MP0005174_abnormal_tail_pigmentation | 0.52050582 |
102 | MP0005381_digestive/alimentary_phenotyp | 0.51563110 |
103 | MP0009840_abnormal_foam_cell | 0.50673715 |
104 | MP0004185_abnormal_adipocyte_glucose | 0.50637153 |
105 | MP0003453_abnormal_keratinocyte_physiol | 0.50364294 |
106 | MP0000604_amyloidosis | 0.50097462 |
107 | MP0000350_abnormal_cell_proliferation | 0.49648704 |
108 | MP0008873_increased_physiological_sensi | 0.49238966 |
109 | MP0008007_abnormal_cellular_replicative | 0.48514033 |
110 | MP0001765_abnormal_ion_homeostasis | 0.47356131 |
111 | MP0000313_abnormal_cell_death | 0.47066693 |
112 | MP0003075_altered_response_to | 0.47065535 |
113 | MP0003183_abnormal_peptide_metabolism | 0.46805897 |
114 | MP0001216_abnormal_epidermal_layer | 0.45662893 |
115 | MP0003690_abnormal_glial_cell | 0.45252660 |
116 | MP0001730_embryonic_growth_arrest | 0.45208745 |
117 | MP0002136_abnormal_kidney_physiology | 0.44641253 |
118 | MP0005164_abnormal_response_to | 0.44486933 |
119 | MP0008569_lethality_at_weaning | 0.43280771 |
120 | MP0003091_abnormal_cell_migration | 0.41884561 |
121 | MP0002822_catalepsy | 0.41549109 |
122 | MP0002693_abnormal_pancreas_physiology | 0.40248715 |
123 | MP0008995_early_reproductive_senescence | 0.39754807 |
124 | MP0000367_abnormal_coat/_hair | 0.39582939 |
125 | MP0002083_premature_death | 0.39555326 |
126 | MP0005166_decreased_susceptibility_to | 0.39260951 |
127 | MP0001191_abnormal_skin_condition | 0.38733322 |
128 | MP0003959_abnormal_lean_body | 0.37420272 |
129 | MP0001348_abnormal_lacrimal_gland | 0.37280616 |
130 | MP0008770_decreased_survivor_rate | 0.37274010 |
131 | MP0009643_abnormal_urine_homeostasis | 0.34800172 |
132 | MP0004130_abnormal_muscle_cell | 0.33696844 |
133 | MP0003172_abnormal_lysosome_physiology | 0.33447691 |
Rank | Gene Set | Z-score |
---|---|---|
1 | T lymphocytopenia (HP:0005403) | 9.00450391 |
2 | Abnormality of T cell number (HP:0011839) | 8.60195803 |
3 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.91416232 |
4 | Severe combined immunodeficiency (HP:0004430) | 5.90119978 |
5 | Abnormality of T cells (HP:0002843) | 5.89145627 |
6 | Combined immunodeficiency (HP:0005387) | 5.72858016 |
7 | Stomatitis (HP:0010280) | 5.65146238 |
8 | Nasal polyposis (HP:0100582) | 5.19312774 |
9 | Panhypogammaglobulinemia (HP:0003139) | 5.11038721 |
10 | Recurrent viral infections (HP:0004429) | 4.94339914 |
11 | Recurrent fungal infections (HP:0002841) | 4.77905280 |
12 | Chronic otitis media (HP:0000389) | 4.67199745 |
13 | Recurrent bronchitis (HP:0002837) | 4.59207673 |
14 | IgG deficiency (HP:0004315) | 4.41850061 |
15 | Abnormality of the nasal mucosa (HP:0000433) | 4.28301297 |
16 | Eosinophilia (HP:0001880) | 4.16460112 |
17 | Eczematoid dermatitis (HP:0000976) | 4.00893572 |
18 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.97768082 |
19 | Abnormality of eosinophils (HP:0001879) | 3.96674835 |
20 | Pustule (HP:0200039) | 3.89605296 |
21 | IgM deficiency (HP:0002850) | 3.86945150 |
22 | Abnormality of B cell number (HP:0010975) | 3.86541794 |
23 | B lymphocytopenia (HP:0010976) | 3.86541794 |
24 | Abnormality of the fingertips (HP:0001211) | 3.84545334 |
25 | Recurrent cutaneous fungal infections (HP:0011370) | 3.59203818 |
26 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.59203818 |
27 | Granulocytopenia (HP:0001913) | 3.59060206 |
28 | Chronic diarrhea (HP:0002028) | 3.51753425 |
29 | Leukocytosis (HP:0001974) | 3.48468404 |
30 | Abnormality of the prostate (HP:0008775) | 3.40197825 |
31 | Joint swelling (HP:0001386) | 3.40176509 |
32 | Thyroiditis (HP:0100646) | 3.39414114 |
33 | Myositis (HP:0100614) | 3.36856846 |
34 | Lymphopenia (HP:0001888) | 3.33233025 |
35 | Abnormality of T cell physiology (HP:0011840) | 3.28724471 |
36 | Increased IgM level (HP:0003496) | 3.24091481 |
37 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.22416408 |
38 | Abnormality of macrophages (HP:0004311) | 3.15917038 |
39 | Autoimmune hemolytic anemia (HP:0001890) | 3.13154733 |
40 | Thrombocytosis (HP:0001894) | 3.12522972 |
41 | Spontaneous hematomas (HP:0007420) | 3.07294355 |
42 | Hypoplasia of the thymus (HP:0000778) | 3.05263585 |
43 | Autoimmune thrombocytopenia (HP:0001973) | 2.96916770 |
44 | Gastrointestinal infarctions (HP:0005244) | 2.96584182 |
45 | Orchitis (HP:0100796) | 2.89470164 |
46 | Basal cell carcinoma (HP:0002671) | 2.82713095 |
47 | Lymphoma (HP:0002665) | 2.73468847 |
48 | Gangrene (HP:0100758) | 2.70974204 |
49 | Bronchitis (HP:0012387) | 2.70642096 |
50 | IgA deficiency (HP:0002720) | 2.68903213 |
51 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.54498953 |
52 | Meningitis (HP:0001287) | 2.52743217 |
53 | Increased density of long bones (HP:0006392) | 2.48628915 |
54 | Inflammation of the large intestine (HP:0002037) | 2.46020616 |
55 | Mediastinal lymphadenopathy (HP:0100721) | 2.44893284 |
56 | Abnormality of the pleura (HP:0002103) | 2.43876060 |
57 | Chronic sinusitis (HP:0011109) | 2.43552584 |
58 | Hypergammaglobulinemia (HP:0010702) | 2.41793050 |
59 | Gastrointestinal inflammation (HP:0004386) | 2.41623810 |
60 | Hemoptysis (HP:0002105) | 2.40685262 |
61 | Increased IgE level (HP:0003212) | 2.39769614 |
62 | Encephalitis (HP:0002383) | 2.39554022 |
63 | Abnormal platelet volume (HP:0011876) | 2.38481772 |
64 | Agammaglobulinemia (HP:0004432) | 2.37484737 |
65 | Hypochromic anemia (HP:0001931) | 2.36781840 |
66 | Papilloma (HP:0012740) | 2.36215605 |
67 | Verrucae (HP:0200043) | 2.36215605 |
68 | Increased CSF protein (HP:0002922) | 2.33510522 |
69 | Vasculitis (HP:0002633) | 2.32538796 |
70 | Microvesicular hepatic steatosis (HP:0001414) | 2.26618145 |
71 | Keratoconjunctivitis (HP:0001096) | 2.26419678 |
72 | Renal cortical cysts (HP:0000803) | 2.25941854 |
73 | Recurrent sinusitis (HP:0011108) | 2.24158286 |
74 | Acute hepatic failure (HP:0006554) | 2.23039716 |
75 | Urticaria (HP:0001025) | 2.22940119 |
76 | Keratoconjunctivitis sicca (HP:0001097) | 2.22082083 |
77 | Sensory axonal neuropathy (HP:0003390) | 2.21855553 |
78 | Recurrent otitis media (HP:0000403) | 2.20683677 |
79 | Malnutrition (HP:0004395) | 2.19844704 |
80 | Recurrent skin infections (HP:0001581) | 2.18594907 |
81 | Recurrent abscess formation (HP:0002722) | 2.17529633 |
82 | Chest pain (HP:0100749) | 2.15715568 |
83 | Obstructive lung disease (HP:0006536) | 2.13744793 |
84 | Chronic obstructive pulmonary disease (HP:0006510) | 2.13744793 |
85 | Epistaxis (HP:0000421) | 2.12549407 |
86 | Micronodular cirrhosis (HP:0001413) | 2.07297137 |
87 | Bronchiectasis (HP:0002110) | 2.07017736 |
88 | Amaurosis fugax (HP:0100576) | 2.06322747 |
89 | Stomach cancer (HP:0012126) | 2.04963980 |
90 | Prolonged bleeding time (HP:0003010) | 2.03133464 |
91 | Testicular atrophy (HP:0000029) | 2.03034096 |
92 | Skin rash (HP:0000988) | 2.02948333 |
93 | Pulmonary infiltrates (HP:0002113) | 2.02841284 |
94 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.02135729 |
95 | Arterial thrombosis (HP:0004420) | 1.99715161 |
96 | Bicuspid aortic valve (HP:0001647) | 1.99428459 |
97 | Abnormality of the pericardium (HP:0001697) | 1.96814249 |
98 | Poikiloderma (HP:0001029) | 1.96697711 |
99 | Persistence of primary teeth (HP:0006335) | 1.96660449 |
100 | Dysphonia (HP:0001618) | 1.96584663 |
101 | Pulmonary fibrosis (HP:0002206) | 1.95741700 |
102 | Abnormality of oral frenula (HP:0000190) | 1.95693145 |
103 | Alveolar cell carcinoma (HP:0006519) | 1.94653578 |
104 | Cheilitis (HP:0100825) | 1.94324367 |
105 | Increased mean platelet volume (HP:0011877) | 1.92719026 |
106 | Polyneuropathy (HP:0001271) | 1.92701591 |
107 | Glomerulopathy (HP:0100820) | 1.92134224 |
108 | Ureteral stenosis (HP:0000071) | 1.88676175 |
109 | Bile duct proliferation (HP:0001408) | 1.87704501 |
110 | Abnormal biliary tract physiology (HP:0012439) | 1.87704501 |
111 | Abnormality of male internal genitalia (HP:0000022) | 1.86507050 |
112 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.85880615 |
113 | 3-Methylglutaconic aciduria (HP:0003535) | 1.85469027 |
114 | Dyschromatopsia (HP:0007641) | 1.85380542 |
115 | Retrobulbar optic neuritis (HP:0100654) | 1.85118936 |
116 | Optic neuritis (HP:0100653) | 1.85118936 |
117 | Pulmonary embolism (HP:0002204) | 1.84966642 |
118 | Hypoproteinemia (HP:0003075) | 1.84305922 |
119 | Hepatosplenomegaly (HP:0001433) | 1.83469551 |
120 | Anorexia (HP:0002039) | 1.83391588 |
121 | Hepatitis (HP:0012115) | 1.82654098 |
122 | Pancytopenia (HP:0001876) | 1.81970398 |
123 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.81733025 |
124 | Gingival bleeding (HP:0000225) | 1.80817579 |
125 | Frequent falls (HP:0002359) | 1.80196174 |
126 | Acute myeloid leukemia (HP:0004808) | 1.78765013 |
127 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.76025328 |
128 | Dislocated radial head (HP:0003083) | 1.75463722 |
129 | Entropion (HP:0000621) | 1.74652401 |
130 | Periodontitis (HP:0000704) | 1.73946016 |
131 | Trigonocephaly (HP:0000243) | 1.70106024 |
132 | Ureteral obstruction (HP:0006000) | 1.68896699 |
133 | Cellular immunodeficiency (HP:0005374) | 1.67146772 |
134 | Abnormal number of erythroid precursors (HP:0012131) | 1.65399636 |
135 | Recurrent bacterial skin infections (HP:0005406) | 1.64558183 |
136 | Broad palm (HP:0001169) | 1.62887503 |
137 | Abnormality of the radial head (HP:0003995) | 1.62692162 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TXK | 6.21251221 |
2 | MAP4K1 | 6.14517329 |
3 | ITK | 3.52399877 |
4 | ZAP70 | 3.46431633 |
5 | JAK3 | 3.27760517 |
6 | STK10 | 2.71688598 |
7 | FGFR4 | 2.61114749 |
8 | NLK | 2.58437427 |
9 | IKBKE | 2.18094997 |
10 | GRK6 | 2.16600125 |
11 | TYK2 | 2.08206004 |
12 | EEF2K | 2.06439577 |
13 | LCK | 1.92024354 |
14 | TEC | 1.91612123 |
15 | FGFR3 | 1.90348175 |
16 | CAMKK2 | 1.86313177 |
17 | MAPK11 | 1.85474626 |
18 | SCYL2 | 1.79695006 |
19 | CSK | 1.73784813 |
20 | PRPF4B | 1.68897497 |
21 | PKN2 | 1.68200010 |
22 | MST4 | 1.67767735 |
23 | CAMKK1 | 1.60001048 |
24 | MAP3K14 | 1.57625063 |
25 | RIPK4 | 1.52260454 |
26 | MAP3K10 | 1.50978100 |
27 | NME2 | 1.49060740 |
28 | SYK | 1.41598867 |
29 | PRKCH | 1.38785026 |
30 | JAK1 | 1.37144034 |
31 | LRRK2 | 1.35222952 |
32 | BTK | 1.34812294 |
33 | HCK | 1.34663215 |
34 | KIT | 1.34656809 |
35 | GRK7 | 1.23696197 |
36 | PRKCQ | 1.23510526 |
37 | FLT3 | 1.23454212 |
38 | TBK1 | 1.20147208 |
39 | MAP3K13 | 1.16881193 |
40 | MAP3K7 | 1.11173289 |
41 | IKBKB | 1.05895082 |
42 | RPS6KA4 | 1.04410689 |
43 | TRIB3 | 1.03051673 |
44 | TAOK3 | 1.01918305 |
45 | CDK12 | 1.01661183 |
46 | FES | 0.99865856 |
47 | ERN1 | 0.95244840 |
48 | TAOK1 | 0.93899953 |
49 | PIM1 | 0.92131859 |
50 | BCR | 0.91548941 |
51 | TYRO3 | 0.89432173 |
52 | MARK3 | 0.89320823 |
53 | PASK | 0.86775913 |
54 | ADRBK2 | 0.86773051 |
55 | BLK | 0.86489250 |
56 | EIF2AK1 | 0.84426305 |
57 | CLK1 | 0.84021067 |
58 | CHUK | 0.83230505 |
59 | PDGFRB | 0.81784984 |
60 | TAOK2 | 0.81648512 |
61 | IRAK4 | 0.81336094 |
62 | JAK2 | 0.79254923 |
63 | EPHB1 | 0.77951351 |
64 | PIK3CG | 0.75784753 |
65 | KDR | 0.74938090 |
66 | MELK | 0.73052449 |
67 | LYN | 0.72745020 |
68 | MARK2 | 0.69391183 |
69 | CSF1R | 0.69284880 |
70 | ALK | 0.66577411 |
71 | NME1 | 0.65488697 |
72 | SIK2 | 0.64262429 |
73 | FGFR1 | 0.60761637 |
74 | TESK2 | 0.58354498 |
75 | PDK1 | 0.57874477 |
76 | MAP2K3 | 0.57584711 |
77 | TLK1 | 0.57328180 |
78 | TGFBR1 | 0.56588002 |
79 | TNK2 | 0.55693804 |
80 | CDK4 | 0.55402580 |
81 | MAPK12 | 0.54954969 |
82 | RIPK1 | 0.52526677 |
83 | PIK3CA | 0.50261311 |
84 | RAF1 | 0.50173588 |
85 | RPS6KB2 | 0.50129089 |
86 | TTN | 0.48465866 |
87 | MAP3K8 | 0.45717940 |
88 | MAPK7 | 0.45698426 |
89 | PIM2 | 0.45334922 |
90 | STK4 | 0.43593910 |
91 | CDC7 | 0.43519033 |
92 | NUAK1 | 0.43262659 |
93 | INSR | 0.42771835 |
94 | TGFBR2 | 0.42736360 |
95 | HIPK2 | 0.42355896 |
96 | EPHA3 | 0.42326244 |
97 | FGFR2 | 0.42240610 |
98 | TSSK6 | 0.41192297 |
99 | PTK6 | 0.40991517 |
100 | STK11 | 0.40909265 |
101 | TESK1 | 0.39953398 |
102 | FYN | 0.37336567 |
103 | RPS6KA5 | 0.36899248 |
104 | MAPKAPK3 | 0.36785385 |
105 | MAPKAPK2 | 0.36744056 |
106 | MAP3K11 | 0.35114632 |
107 | STK24 | 0.35063999 |
108 | BMPR2 | 0.34801593 |
109 | TRPM7 | 0.34092100 |
110 | WNK4 | 0.32749994 |
111 | PDPK1 | 0.32393242 |
112 | MAP2K6 | 0.30643525 |
113 | ROCK2 | 0.30516466 |
114 | ACVR1B | 0.30115729 |
115 | PRKD2 | 0.30040634 |
116 | CDK9 | 0.29934937 |
117 | NTRK2 | 0.26588091 |
118 | ZAK | 0.26194914 |
119 | RPS6KA6 | 0.26008080 |
120 | IGF1R | 0.25929040 |
121 | EGFR | 0.25927378 |
122 | BRD4 | 0.25920335 |
123 | DMPK | 0.25147349 |
124 | MAPK4 | 0.24809022 |
125 | MAP3K3 | 0.24627280 |
126 | CDK6 | 0.23767374 |
127 | RPS6KA1 | 0.23253282 |
128 | EIF2AK3 | 0.21821118 |
129 | MAPK3 | 0.21655050 |
130 | SIK3 | 0.20347322 |
131 | CHEK1 | 0.20163381 |
132 | VRK1 | 0.16191058 |
133 | MAP2K2 | 0.15792794 |
134 | FGR | 0.15780758 |
135 | PRKCB | 0.13560842 |
136 | PRKCD | 0.13504188 |
137 | YES1 | 0.11653341 |
138 | MAPK9 | 0.11592311 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 5.48536274 |
2 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 4.32187470 |
3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.52686666 |
4 | Allograft rejection_Homo sapiens_hsa05330 | 3.14595373 |
5 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 3.04458069 |
6 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.93109195 |
7 | Measles_Homo sapiens_hsa05162 | 2.80095346 |
8 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.59156787 |
9 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.55511444 |
10 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.32287598 |
11 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.09091748 |
12 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.06633859 |
13 | Leishmaniasis_Homo sapiens_hsa05140 | 1.96787635 |
14 | Viral myocarditis_Homo sapiens_hsa05416 | 1.80163494 |
15 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.79442114 |
16 | Ribosome_Homo sapiens_hsa03010 | 1.76287875 |
17 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.69796506 |
18 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.63016755 |
19 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.60451824 |
20 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.59444887 |
21 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.53680311 |
22 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.46191717 |
23 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.39371250 |
24 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.38709511 |
25 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.35392392 |
26 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.30337774 |
27 | Hepatitis B_Homo sapiens_hsa05161 | 1.29992753 |
28 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.27708085 |
29 | HTLV-I infection_Homo sapiens_hsa05166 | 1.25448052 |
30 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.19741742 |
31 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.18989495 |
32 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.18021905 |
33 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.17170657 |
34 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.13641323 |
35 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.11971890 |
36 | Colorectal cancer_Homo sapiens_hsa05210 | 1.11122384 |
37 | Influenza A_Homo sapiens_hsa05164 | 1.09982610 |
38 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.08418517 |
39 | Shigellosis_Homo sapiens_hsa05131 | 1.06404422 |
40 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.02985136 |
41 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.99804396 |
42 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.99374488 |
43 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.95075835 |
44 | Legionellosis_Homo sapiens_hsa05134 | 0.91821894 |
45 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.90118642 |
46 | Apoptosis_Homo sapiens_hsa04210 | 0.89692953 |
47 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.87561296 |
48 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.85176852 |
49 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.84594609 |
50 | Thyroid cancer_Homo sapiens_hsa05216 | 0.82359639 |
51 | Spliceosome_Homo sapiens_hsa03040 | 0.81792366 |
52 | Malaria_Homo sapiens_hsa05144 | 0.80777358 |
53 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.80546679 |
54 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.77777512 |
55 | Hepatitis C_Homo sapiens_hsa05160 | 0.76981854 |
56 | Platelet activation_Homo sapiens_hsa04611 | 0.76969312 |
57 | Tuberculosis_Homo sapiens_hsa05152 | 0.66599678 |
58 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.65631332 |
59 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.65474403 |
60 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.65064303 |
61 | Pertussis_Homo sapiens_hsa05133 | 0.64212527 |
62 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.64052293 |
63 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.63056702 |
64 | Salmonella infection_Homo sapiens_hsa05132 | 0.62347899 |
65 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.60648393 |
66 | Endometrial cancer_Homo sapiens_hsa05213 | 0.57517812 |
67 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.57125586 |
68 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.56406451 |
69 | Asthma_Homo sapiens_hsa05310 | 0.54909673 |
70 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.53539583 |
71 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.52936873 |
72 | Proteasome_Homo sapiens_hsa03050 | 0.50618574 |
73 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.49174125 |
74 | Prostate cancer_Homo sapiens_hsa05215 | 0.47450898 |
75 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.46882754 |
76 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.46825597 |
77 | DNA replication_Homo sapiens_hsa03030 | 0.46385880 |
78 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.46383528 |
79 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.44659863 |
80 | RNA degradation_Homo sapiens_hsa03018 | 0.44609247 |
81 | RNA transport_Homo sapiens_hsa03013 | 0.41679105 |
82 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.40132546 |
83 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.39835663 |
84 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.39506093 |
85 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.38865458 |
86 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.38831291 |
87 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.38712112 |
88 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.37505084 |
89 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.37101104 |
90 | Endocytosis_Homo sapiens_hsa04144 | 0.36985269 |
91 | Base excision repair_Homo sapiens_hsa03410 | 0.35388404 |
92 | Circadian rhythm_Homo sapiens_hsa04710 | 0.35283259 |
93 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.34804753 |
94 | RNA polymerase_Homo sapiens_hsa03020 | 0.34108664 |
95 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.34004891 |
96 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.33981580 |
97 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.31931354 |
98 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.31746987 |
99 | Insulin resistance_Homo sapiens_hsa04931 | 0.30321451 |
100 | Sulfur relay system_Homo sapiens_hsa04122 | 0.29836058 |
101 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.29522913 |
102 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.29446211 |
103 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.28450093 |
104 | Adherens junction_Homo sapiens_hsa04520 | 0.28367293 |
105 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.28169395 |
106 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.28151692 |
107 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.27207682 |
108 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.26569105 |
109 | Pathways in cancer_Homo sapiens_hsa05200 | 0.25129102 |
110 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.24426339 |
111 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.23555114 |
112 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.23491326 |
113 | Mismatch repair_Homo sapiens_hsa03430 | 0.22264858 |
114 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.22252049 |
115 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.21577278 |
116 | Phagosome_Homo sapiens_hsa04145 | 0.19644482 |
117 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.15522618 |
118 | Lysine degradation_Homo sapiens_hsa00310 | 0.15110266 |
119 | Lysosome_Homo sapiens_hsa04142 | 0.14963718 |
120 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.13462796 |
121 | Prion diseases_Homo sapiens_hsa05020 | 0.12085428 |
122 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.11401109 |
123 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.09910373 |
124 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.08831591 |
125 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.07973522 |
126 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.06163929 |
127 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.05866223 |